Search Results for: CEP350

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ADIPOR1 adiponectin receptor 1
  • AMPK inhibits chREBP transcriptional activation activity
  • AMPK inhibits chREBP transcriptional activation activity
Novel APH1A aph-1 homolog A, gamma-secretase subunit
  • Nuclear signaling by ERBB4
  • Regulated proteolysis of p75NTR
  • NRIF signals cell death from the nucleus
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • EPH-ephrin mediated repulsion of cells
  • NOTCH3 Activation and Transmission of Signal to the Nucleus
  • NOTCH4 Activation and Transmission of Signal to the Nucleus
  • Noncanonical activation of NOTCH3
  • Amyloid fiber formation
  • E-2012
Novel ID3 inhibitor of DNA binding 3, HLH protein
  • NGF-stimulated transcription
Novel RSRP1 arginine and serine rich protein 1
APTX aprataxin
  • Coenzyme Q10 deficiency
  • Ataxia with ocular apraxia (AOA), including: Ataxia telangiectasia (AT); Ataxia telangiectasia like disorder (ATLD); Ataxia oculomotor apraxia type 1 (AOA1); Ataxia oculomotor apraxia type 2 (AOA2)
CEP19 centrosomal protein 19
NR1H3 nuclear receptor subfamily 1 group H member 3
  • PPARA activates gene expression
  • VLDLR internalisation and degradation
  • NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
  • NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake
  • NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose
  • NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
  • NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis
  • TO-901317
  • N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE
  • 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
  • (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID
  • Diacerein
  • Rhein
PLEKHA5 pleckstrin homology domain containing A5
  • Synthesis of PIPs at the plasma membrane
PPARA peroxisome proliferator activated receptor alpha
  • RORA activates gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • PPARA activates gene expression
  • PPARA activates gene expression
  • Transcriptional activation of mitochondrial biogenesis
  • Activation of gene expression by SREBF (SREBP)
  • Transcriptional regulation of white adipocyte differentiation
  • Nuclear Receptor transcription pathway
  • Regulation of lipid metabolism by PPARalpha
  • Circadian Clock
  • SUMOylation of intracellular receptors
  • alpha-Linolenic acid
  • Icosapent
  • Troglitazone
  • Valproic acid
  • Indomethacin
  • Rosiglitazone
  • Fenoprofen
  • Clofibrate
  • Fenofibrate
  • Ibuprofen
  • Amiodarone
  • Gemfibrozil
  • Bezafibrate
  • Prasterone
  • N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide
  • Flufenamic acid
  • Resveratrol
  • Phthalic Acid
  • Lauric acid
  • Stearic acid
  • Doconexent
  • Palmitic Acid
  • Oleic Acid
  • Caprylic acid
  • Arachidonic Acid
  • Reglitazar
  • Elafibranor
  • Cardarine
  • Muraglitazar
  • Ertiprotafib
  • Ragaglitazar
  • Tesaglitazar
  • GW-590735
  • Indeglitazar
  • Myristic acid
  • Aleglitazar
  • Clinofibrate
  • Ciprofibrate
  • Dexibuprofen
  • Soybean oil
  • Omega-3 fatty acids
  • Myrrh
  • Isoflavone
  • Leukotriene B4
  • Fenofibric acid
  • Fish oil
PPARD peroxisome proliferator activated receptor delta
  • Carnitine metabolism
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Nuclear Receptor transcription pathway
  • Signaling by Retinoic Acid
  • alpha-Linolenic acid
  • Icosapent
  • Troglitazone
  • Valproic acid
  • Treprostinil
  • Rosiglitazone
  • Sulindac
  • Bezafibrate
  • Phthalic Acid
  • Heptyl glucoside
  • Oleic Acid
  • cis-Vaccenic acid
  • Elafibranor
  • KD3010
  • Cardarine
  • (2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid
  • 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid
  • Indeglitazar
  • {4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid
  • Clinofibrate
  • Glycerin
  • Fenofibric acid
  • Fish oil
PPARG peroxisome proliferator activated receptor gamma
  • PPARA activates gene expression
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • Nuclear Receptor transcription pathway
  • SUMOylation of intracellular receptors
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • MECP2 regulates transcription factors
  • alpha-Linolenic acid
  • Icosapent
  • Troglitazone
  • Mesalazine
  • Valproic acid
  • Indomethacin
  • Rosiglitazone
  • Fenoprofen
  • Nateglinide
  • Sulfasalazine
  • Clofazimine
  • Repaglinide
  • Telmisartan
  • Balsalazide
  • Ibuprofen
  • Glipizide
  • Amiodarone
  • Pioglitazone
  • Mitiglinide
  • Bezafibrate
  • Flufenamic acid
  • Resveratrol
  • Phthalic Acid
  • Capric acid
  • Doconexent
  • Oleic Acid
  • (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid
  • 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
  • Reglitazar
  • Elafibranor
  • AMG-131
  • CLX-0921
  • Muraglitazar
  • Ertiprotafib
  • Ragaglitazar
  • Tesaglitazar
  • (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID
  • (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
  • 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID
  • (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid
  • (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid
  • (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid
  • (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid
  • 9(S)-HODE
  • difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron
  • (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID
  • 3-(5-methoxy-1H-indol-3-yl)propanoic acid
  • Indeglitazar
  • (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid
  • 2-chloro-5-nitro-N-phenylbenzamide
  • (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid
  • 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid
  • 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
  • (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid
  • 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE
  • Triclosan
  • (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid
  • Aleglitazar
  • Clinofibrate
  • Cannabidiol
  • Lobeglitazone
  • Ciglitazone
  • Dexibuprofen
  • Omega-3 fatty acids
  • Curcumin
  • Arhalofenate
  • Isoflavone
  • Naveglitazar
  • Fenofibric acid
  • Fish oil
  • Medical Cannabis
  • Nabiximols
  • Darglitazone
  • Curcumin sulfate
  • Type II diabetes mellitus
  • Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
  • Thyroid cancer

Page 1 out of 1 pages